[1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D007538:Isoniazid; D011044:Poland; D013183:Sputum; D013223:Statistics as Topic; D013307:Streptomycin; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D010131:Aminosalicylic Acid; D007538:Isoniazid; D013307:Streptomycin
AMINOSALICYLIC ACID; DRUG RESISTANCE, MICROBIAL; ISONIAZID; POLAND; SPUTUM; STATISTICS; STREPTOMYCIN; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY
WYNIKI ROCZNEGO LECZENIA PRZECIWPR ATKOWEGO W NOWO WYKRYTEJ JAMISTEJ GRU'ZLICY PLUC.